BioVie Inc. Retained Earnings
BioVie Inc. (BIVI) had Retained Earnings of -$374.26 million as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$374.26M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$368.62M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$363.34M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$357.28M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$374.26M 10-K · filed 2026-08-13 |
| 2026-03-31 | -$368.62M S-1/A · filed 2026-08-06 |
| 2025-12-31 | -$363.34M 10-Q · filed 2026-02-06 |
| 2025-09-30 | -$357.28M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$352.14M 10-K · filed 2026-08-13 |
| 2025-03-31 | -$348.66M 10-Q · filed 2025-05-12 |
| 2024-12-31 | -$345.87M 10-Q · filed 2025-02-11 |
| 2024-09-30 | -$338.71M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$334.23M S-1/A · filed 2026-08-06 |
| 2024-03-31 | -$329.29M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$320.34M 10-Q · filed 2024-02-13 |
| 2023-09-30 | -$311.94M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$301.23M 10-K · filed 2024-09-30 |
| 2023-03-31 | -$292.11M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$277.07M 10-Q · filed 2023-02-10 |
| 2022-09-30 | -$261.39M 10-Q · filed 2022-11-04 |
| 2022-06-30 | -$250.97M 10-K · filed 2023-08-16 |
| 2022-03-31 | -$242.88M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$235.84M 10-Q · filed 2022-02-08 |
| 2021-09-30 | -$230.43M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$224.89M 10-K · filed 2022-09-27 |
| 2021-03-31 | -$93.35M 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$90.36M 10-Q · filed 2021-01-29 |
| 2020-09-30 | -$87.30M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$41.04M 10-K · filed 2021-08-30 |
| 2020-03-31 | -$21.88M 10-Q · filed 2020-05-13 |
| 2019-12-31 | -$21.52M 10-Q · filed 2020-02-13 |
| 2019-09-30 | -$28.18M 10-Q · filed 2019-11-19 |
| 2019-06-30 | -$7.26M 10-K/A · filed 2020-08-07 |
| 2019-05-10 | -$6.61M 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$5.76M 10-Q · filed 2019-02-12 |
| 2018-09-30 | -$5.26M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$4.77M 10-K · filed 2019-09-27 |
| 2018-03-31 | -$4.19M 10-Q · filed 2018-05-14 |
| 2017-12-31 | -$3.50M 10-Q · filed 2018-02-14 |
| 2017-09-30 | -$3.00M 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$2.34M 10-K · filed 2018-10-05 |
| 2017-03-31 | -$1.89M 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$1.71M 10-Q · filed 2017-02-07 |
| 2016-09-30 | -$1.36M 10-Q/A · filed 2017-01-19 |
| 2016-06-30 | -$1.00M 10-K · filed 2017-08-24 |
| 2016-03-31 | -$734.67K 10-Q · filed 2016-05-23 |
| 2015-06-30 | -$572.41K 10-K · filed 2016-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |